Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedAdds the disease focus Multiple myeloma and a related topics link (MedlinePlus Genetics) to the page to clarify the study context and provide a nearby resource. The page revision is updated from v3.6.3 to v3.6.4.SummaryDifference0.2%

- Check9 days agoChange DetectedThe related topics section was altered by removing the header and the entries for 'Multiple myeloma' and 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe related topics area now includes 'Multiple myeloma' and a 'MedlinePlus Genetics' link, and the revision tag was updated to v3.6.3 from v3.6.2.SummaryDifference0.2%

- Check31 days agoChange DetectedAdded 'Revision: v3.6.2' in the page footer and removed specific related topics entries (e.g., 'Multiple myeloma' and 'MedlinePlus Genetics'), along with deleting the older 'Revision: v3.6.0' text.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page now includes additional related topic entries, specifically listing Multiple myeloma and linking to MedlinePlus Genetics under the related topics section, expanding access to disease information within the study context.SummaryDifference0.2%

- Check46 days agoChange DetectedAdds a recruitment status note ('No longer looking for participants') and new help/navigation items ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with an updated revision tag (Revision: v3.6.0). It also removes older topics and sections ('Intervention / Treatment', 'Multiple myeloma', MedlinePlus Genetics, and the prior revision tag Revision: v3.5.5).SummaryDifference0.7%

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.